Streetbeat News

Regulatory

FXI

NVO

China's Medical Products Authority has approved Novo Nordisk's Type-2 diabetes treatment for entry into the Chinese market.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:53 pm

AYRWF

CRLBF

CURLF

GTBIF

TCNNF

VRNOF

Florida's cannabis legalization amendment has shattered fundraising records, with Smart & Safe Florida raising over $40 million. Trulieve (OTCQX:TCNNF) has been the largest donor, contributing over $54 million. Other cannabis companies like Verano Holdings (OTCQX:VRNOF), Curaleaf Holdings (OTCQX:CURLF), AYR Wellness (OTCQX:AYRWF), Cresco Labs (OTCQX:CRLBF), and Green Thumb Industries (OTCQX:GTBIF) have also contributed. Despite opposition from Gov. Ron DeSantis, the amendment has strong public support.

Portfolio Pulse from Maureen Meehan

June 24, 2024 | 12:53 pm

SPY

Federal Reserve's Goolsbee emphasized that political considerations will not influence the Fed's monetary policy decisions.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:46 pm

SPY

Federal Reserve's Goolsbee refrains from commenting on the state of government finances, as reported by CNBC.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:45 pm

SPY

Federal Reserve's Goolsbee emphasizes the importance of public understanding of the Fed's reaction function, which could influence market expectations and investor behavior.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:39 pm

SPY

Federal Reserve's Goolsbee stated that the economy, excluding inflation data, is showing signs of cooling. This could impact market sentiment and influence the performance of broad market ETFs like SPY.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:37 pm

SPY

Federal Reserve's Goolsbee stated that current Fed policy is restrictive, but slowing inflation data could lead to easier policy. He is optimistic about improvement in inflation data and hopeful that inflation will head back to 2%.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:36 pm

ICE

Intercontinental Exchange (ICE) is set to launch a new clearing service for U.S. Treasury securities and repurchasing agreements, following a mandate from the SEC aimed at enhancing market resilience.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:32 pm

IMNN

IMUNON has announced the database lock for its Phase 2 OVATION 2 study, which evaluates the safety and efficacy of IMNN-001, a novel IL-12 immunotherapy, in advanced ovarian cancer. The treatment is administered alongside the standard of care as a first-line treatment.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:32 pm

BFRI

Biofrontera Inc. (NASDAQ:BFRI) has launched its FDA-approved RhodoLED XL lamp, designed for use with Ameluz® gel in photodynamic therapy for actinic keratoses. The company began commercial distribution on June 10, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:31 pm